Expand IDNA Menu
IDNA MENU

IDNA ETF Profile


Family: Blackrock (iShares)
Name: iShares Genomics Immunology and Healthcare ETF
Inception Date: 11-Jun-2019
Termination Date:
Investment Objective: The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
Prospectus
Top 10 Holdings
EXELIXIS INC EXEL 6.4910%
GILEAD SCIENCES INC GILD 5.7535%
INCYTE CORP INCY 4.9390%
BEIGENE LTD 6160 4.9317%
REVOLUTION MEDICINES INC RVMD 4.7258%
BIONTECH SE ADR BNTX 4.6946%
ROCHE HOLDING PAR AG ROG 4.2812%
SAREPTA THERAPEUTICS INC SRPT 4.1418%
TAKEDA PHARMACEUTICAL LTD 4502 4.0351%
SANOFI SA SAN 3.9393%
Top 10 Holdings Weight: 47.9%
Number of Holdings: 62
Shares Outstanding: 5,700,000
Total Net Assets: 137,769,600
NAV: 24.24
Net Expense Ratio: 0.47%
Asset Class: Equities (Stocks)
Developed or Emerging: Developed Market Funds
Country:
Region:
Strategy:
Currency:
Commodity:
Sector: Healthcare
Industry: Biotech
Dividend Type:
Tax Exempt State:
Maturity Duration:
Market Cap: Broad Market / Multi-Cap
Credit Quality:
Mortgage Bond Types:
Bond Type:
Gov't Bond Types:
Reit Type:
Leverage Direction/Factor:
Is Currency Hedged: No
US or Ex-US: Global